{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T09:03:34Z","timestamp":1770282214986,"version":"3.49.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02573-9","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T08:23:17Z","timestamp":1745396597000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Temporal evolution and factors influencing visual function and RNFL thickness in ethambutol-associated optic neuropathy"],"prefix":"10.1186","volume":"30","author":[{"given":"Taimin","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yurong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"3","key":"2573_CR1","doi-asserted-by":"publisher","first-page":"729","DOI":"10.4103\/ijo.IJO_1920_22","volume":"71","author":"S Sabhapandit","year":"2023","unstructured":"Sabhapandit S, Gella V, Shireesha A, et al. Ethambutol optic neuropathy in the extended anti-tubercular therapy regime: a systematic review. Indian J Ophthalmol. 2023;71(3):729\u201335.","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"2573_CR2","volume":"17","author":"P Singh","year":"2025","unstructured":"Singh P, Karkhur S, Verma V. Ethambutol-induced optic neuropathy: a retrospective study of incidences and risk factors. Cureus. 2025;17(2): e79160.","journal-title":"Cureus"},{"issue":"6","key":"2573_CR3","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1080\/08820538.2022.2085517","volume":"37","author":"S Sen","year":"2022","unstructured":"Sen S, Mandal S, Banerjee M, et al. Ethambutol-induced optic neuropathy: functional and structural changes in the retina and optic nerve. Semin Ophthalmol. 2022;37(6):730\u20139.","journal-title":"Semin Ophthalmol"},{"issue":"3","key":"2573_CR4","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.4103\/ijo.IJO_2997_21","volume":"70","author":"PK Panigrahi","year":"2022","unstructured":"Panigrahi PK. Comment on: Ethambutol toxicity: expert panel consensus for the primary prevention, diagnosis, and management of ethambutol-induced optic neuropathy. Indian J Ophthalmol. 2022;70(3):1069\u201370.","journal-title":"Indian J Ophthalmol"},{"key":"2573_CR5","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2147\/OPTH.S401916","volume":"17","author":"S Srithawatpong","year":"2023","unstructured":"Srithawatpong S, Chaitanuwong P, Yospaiboon Y. Factors affecting visual recovery in patients with ethambutol-induced optic neuropathy. Clin Ophthalmol. 2023;17:545\u201354.","journal-title":"Clin Ophthalmol"},{"issue":"8","key":"2573_CR6","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3390\/toxics12080549","volume":"12","author":"J Kim","year":"2024","unstructured":"Kim J, Ahn SJ. Risk factors of optic neuropathy in ethambutol users: interaction with isoniazid and other associated conditions of toxic optic neuropathy. Toxics. 2024;12(8):549.","journal-title":"Toxics"},{"issue":"2","key":"2573_CR7","doi-asserted-by":"publisher","first-page":"663","DOI":"10.12998\/wjcc.v10.i2.663","volume":"10","author":"WY Sheng","year":"2022","unstructured":"Sheng WY, Wu SQ, Su LY, Zhu LW. Ethambutol-induced optic neuropathy with rare bilateral asymmetry onset: a case report. World J Clin Cases. 2022;10(2):663\u201370.","journal-title":"World J Clin Cases"},{"issue":"3","key":"2573_CR8","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.4103\/ijo.IJO_88_22","volume":"70","author":"R Saxena","year":"2022","unstructured":"Saxena R, Singh D, Phuljhele S, et al. Response to comment on: Ethambutol toxicity: expert panel consensus for the primary prevention, diagnosis, and management of ethambutol-induced optic neuropathy. Indian J Ophthalmol. 2022;70(3):1070\u20131.","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"2573_CR9","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1089\/jop.1995.11.411","volume":"11","author":"LC Woung","year":"1995","unstructured":"Woung LC, Jou JR, Liaw SL. Visual function in recovered ethambutol optic neuropathy. J Ocul Pharmacol Ther. 1995;11(3):411\u20139.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"4","key":"2573_CR10","first-page":"230","volume":"35","author":"JL Goyal","year":"2003","unstructured":"Goyal JL, De Sarmi, Singh NP, Bhatia A. Evaluation of visual functions in patients on ethambutol therapy for tuberculosis: a prospective study. J Commun Dis. 2003;35(4):230\u201343.","journal-title":"J Commun Dis"},{"issue":"9","key":"2573_CR11","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1136\/bjo.2008.148502","volume":"93","author":"V Menon","year":"2009","unstructured":"Menon V, Jain D, Saxena R, Sood R. Prospective evaluation of visual function for early detection of ethambutol toxicity. Br J Ophthalmol. 2009;93(9):1251\u20134.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"2573_CR12","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3109\/15569527.2015.1079784","volume":"35","author":"KL Kim","year":"2016","unstructured":"Kim KL, Park SP. Visual function test for early detection of ethambutol induced ocular toxicity at the subclinical level. Cutan Ocul Toxicol. 2016;35(3):228\u201332.","journal-title":"Cutan Ocul Toxicol"},{"issue":"4","key":"2573_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215297","volume":"14","author":"KW Jin","year":"2019","unstructured":"Jin KW, Lee JY, Rhiu S, Choi DG. Longitudinal evaluation of visual function and structure for detection of subclinical Ethambutol-induced optic neuropathy. PLoS ONE. 2019;14(4): e0215297.","journal-title":"PLoS ONE"},{"issue":"5","key":"2573_CR14","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1517\/14740338.5.5.615","volume":"5","author":"FW Fraunfelder","year":"2006","unstructured":"Fraunfelder FW, Sadun AA, Wood T. Update on ethambutol optic neuropathy. Expert Opin Drug Saf. 2006;5(5):615\u20138.","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"2573_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/WNO.0b013e31818e3c6b","volume":"28","author":"EJ Lee","year":"2008","unstructured":"Lee EJ, Kim SJ, Choung HK, Kim JH, Yu YS. Incidence and clinical features of ethambutol-induced optic neuropathy in Korea. J Neuroophthalmol. 2008;28(4):269\u201377.","journal-title":"J Neuroophthalmol"},{"issue":"4","key":"2573_CR16","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/WNO.0000000000002092","volume":"44","author":"MC Kang","year":"2024","unstructured":"Kang MC, Eun HW, Park KA, Oh SY. Optical coherence tomography parameters and optimal cut-off values for predicting visual prognosis in ethambutol-induced optic neuropathy. J Neuroophthalmol. 2024;44(4):559\u201364.","journal-title":"J Neuroophthalmol"},{"issue":"2","key":"2573_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3341\/kjo.2023.0095","volume":"38","author":"HR An","year":"2024","unstructured":"An HR, Lee BJ, Moon Y. Visual recovery time in patients with ethambutol-induced toxic optic neuropathy. Korean J Ophthalmol. 2024;38(2):91\u20137.","journal-title":"Korean J Ophthalmol"},{"issue":"1\u20133","key":"2573_CR18","first-page":"80","volume":"12","author":"P De Palma","year":"1989","unstructured":"De Palma P, Franco F, Bragliani G, et al. The incidence of optic neuropathy in 84 patients treated with ethambutol. Metab Pediatr Syst Ophthalmol (1985). 1989;12(1\u20133):80\u20132.","journal-title":"Metab Pediatr Syst Ophthalmol (1985)"},{"issue":"7","key":"2573_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.kjms.2015.05.004","volume":"31","author":"SC Chen","year":"2015","unstructured":"Chen SC, Lin MC, Sheu SJ. Incidence and prognostic factor of ethambutol-related optic neuropathy: 10-year experience in southern Taiwan. Kaohsiung J Med Sci. 2015;31(7):358\u201362.","journal-title":"Kaohsiung J Med Sci"},{"issue":"2","key":"2573_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.5588\/ijtld.15.0275","volume":"20","author":"HK Yang","year":"2016","unstructured":"Yang HK, Park MJ, Lee JH, et al. Incidence of toxic optic neuropathy with low-dose ethambutol. Int J Tuberc Lung Dis. 2016;20(2):261\u20134.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"7","key":"2573_CR21","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1136\/bjophthalmol-2020-316897","volume":"105","author":"S Mandal","year":"2021","unstructured":"Mandal S, Saxena R, Dhiman R, et al. Prospective study to evaluate incidence and indicators for early detection of ethambutol toxicity. Br J Ophthalmol. 2021;105(7):1024\u20138.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"2573_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ijtb.2023.11.001","volume":"72","author":"N Sharma","year":"2025","unstructured":"Sharma N, Gahlot A, Goyal JL, et al. Prospective evaluation of ethambutol toxic optic neuropathy in patients of pulmonary tuberculosis. Indian J Tuberc. 2025;72(1):69\u201373.","journal-title":"Indian J Tuberc"},{"issue":"4","key":"2573_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/WNO.0000000000000075","volume":"33","author":"BA Scoville","year":"2013","unstructured":"Scoville BA, De Lott LB, Trobe JD, Mueller BA. Ethambutol optic neuropathy in a hemodialysis patient receiving a guideline-recommended dose. J Neuroophthalmol. 2013;33(4):421\u20133.","journal-title":"J Neuroophthalmol"},{"issue":"6","key":"2573_CR24","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.resinv.2021.06.010","volume":"59","author":"T Ando","year":"2021","unstructured":"Ando T, Kage H, Matsumoto Y, Zokumasu K, Nagase T. Lower dose of ethambutol may reduce ocular toxicity without radiological deterioration for Mycobacterium avium complex pulmonary disease. Respir Investig. 2021;59(6):777\u201382.","journal-title":"Respir Investig"},{"issue":"1","key":"2573_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41433-023-02643-4","volume":"38","author":"S MacVinish","year":"2024","unstructured":"MacVinish S, McMaster D, Moledina T, et al. Ethambutol and visual assessment in England: current practice and recommendations. Eye (Lond). 2024;38(1):112\u20137.","journal-title":"Eye (Lond)"},{"issue":"2","key":"2573_CR26","first-page":"162","volume":"169","author":"A Bastian","year":"1987","unstructured":"Bastian A, Brandt HP. Risk factors for the occurrence of eye damage following ethambutol treatment. Z Erkr Atmungsorgane. 1987;169(2):162\u20135.","journal-title":"Z Erkr Atmungsorgane"},{"issue":"11","key":"2573_CR27","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s00347-003-0823-1","volume":"100","author":"IB Frisch","year":"2003","unstructured":"Frisch IB, Kunze AK, Castro A, Krastel H, Meinck HM. Severe course and contingent risk factors in optic neuropathy and myelopathy after tuberculostatics. Ophthalmologe. 2003;100(11):967\u201370.","journal-title":"Ophthalmologe"},{"issue":"1","key":"2573_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10792-009-9293-z","volume":"30","author":"EK Talbert","year":"2010","unstructured":"Talbert EK, Sadun AA. Risk factors for ethambutol optic toxicity. Int Ophthalmol. 2010;30(1):63\u201372.","journal-title":"Int Ophthalmol"},{"issue":"5","key":"2573_CR29","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1080\/01658107.2022.2100916","volume":"46","author":"P Kaur","year":"2022","unstructured":"Kaur P, Singh S, Kaur K, et al. The genetics of ethambutol-induced optic neuropathy: a narrative review. Neuroophthalmology. 2022;46(5):304\u201313.","journal-title":"Neuroophthalmology"},{"key":"2573_CR30","doi-asserted-by":"publisher","first-page":"1461111","DOI":"10.3389\/fphar.2024.1461111","volume":"15","author":"J Kim","year":"2024","unstructured":"Kim J, Kwon HY, Ahn SJ. Nationwide usage of ethambutol and incidence and screening practices of optic neuropathy. Front Pharmacol. 2024;15:1461111.","journal-title":"Front Pharmacol"},{"issue":"1","key":"2573_CR31","doi-asserted-by":"publisher","first-page":"6257","DOI":"10.1038\/s41598-025-90663-3","volume":"15","author":"KE Han","year":"2025","unstructured":"Han KE, Yoon H, Choi H, Lee JE, Kim SJ. Factors affecting visual outcome in patients with toxic optic neuropathy caused by ethambutol. Sci Rep. 2025;15(1):6257.","journal-title":"Sci Rep"},{"issue":"3","key":"2573_CR32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1136\/bjophthalmol-2018-312063","volume":"103","author":"JY Lee","year":"2019","unstructured":"Lee JY, Han J, Seo JG, Park KA, Oh SY. Diagnostic value of ganglion cell-inner plexiform layer for early detection of ethambutol-induced optic neuropathy. Br J Ophthalmol. 2019;103(3):379\u201384.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"2573_CR33","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1167\/iovs.17-22988","volume":"59","author":"JY Lee","year":"2018","unstructured":"Lee JY, Choi JH, Park KA, Oh SY. Ganglion cell layer and inner plexiform layer as predictors of vision recovery in ethambutol-induced optic neuropathy: a longitudinal OCT analysis. Invest Ophthalmol Vis Sci. 2018;59(5):2104\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"2573_CR34","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1136\/bjophthalmol-2020-317742","volume":"106","author":"L Su","year":"2022","unstructured":"Su L, Li Q, Zhu L, et al. Characterisation of macular superficial vessel density alteration in preclinical ethambutol-induced optic neuropathy using optical coherence tomography angiography. Br J Ophthalmol. 2022;106(3):422\u20136.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"2573_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/WNO.0b013e318205a148","volume":"31","author":"RC Kho","year":"2011","unstructured":"Kho RC, Al-Obailan M, Arnold AC. Bitemporal visual field defects in ethambutol-induced optic neuropathy. J Neuroophthalmol. 2011;31(2):121\u20136.","journal-title":"J Neuroophthalmol"},{"issue":"2","key":"2573_CR36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4103\/0301-4738.77013","volume":"59","author":"S Kedar","year":"2011","unstructured":"Kedar S, Ghate D, Corbett JJ. Visual fields in neuro-ophthalmology. Indian J Ophthalmol. 2011;59(2):103\u20139.","journal-title":"Indian J Ophthalmol"},{"issue":"11","key":"2573_CR37","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1136\/bjophthalmol-2012-301870","volume":"96","author":"HY Chen","year":"2012","unstructured":"Chen HY, Lai SW, Muo CH, Chen PC, Wang IJ. Ethambutol-induced optic neuropathy: a nationwide population-based study from Taiwan. Br J Ophthalmol. 2012;96(11):1368\u201371.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"2573_CR38","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/0168-5597(88)90073-1","volume":"71","author":"JE Petrera","year":"1988","unstructured":"Petrera JE, Fledelius HC, Trojaborg W. Serial pattern evoked potential recording in a case of toxic optic neuropathy due to ethambutol. Electroencephalogr Clin Neurophysiol. 1988;71(2):146\u20139.","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"3","key":"2573_CR39","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jcjo.2018.06.013","volume":"54","author":"V Kanaujia","year":"2019","unstructured":"Kanaujia V, Jain VK, Sharma K, et al. Ethambutol-induced optic neuropathy in renal disorder: a clinico-electrophysiological study. Can J Ophthalmol. 2019;54(3):301\u20135.","journal-title":"Can J Ophthalmol"},{"issue":"5","key":"2573_CR40","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1089\/jop.1997.13.473","volume":"13","author":"RK Tsai","year":"1997","unstructured":"Tsai RK, Lee YH. Reversibility of ethambutol optic neuropathy. J Ocul Pharmacol Ther. 1997;13(5):473\u20137.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"2573_CR41","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12565-023-00736-4","volume":"99","author":"T Ay","year":"2024","unstructured":"Ay T, Akdag UB, Kilincli MF, Ogut E, Barut C. Anatomical variations of foramen of the diaphragma sellae and neighboring structures: a cadaveric study. Anat Sci Int. 2024;99(1):75\u201389.","journal-title":"Anat Sci Int"},{"issue":"12","key":"2573_CR42","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1007\/s00417-015-3150-8","volume":"253","author":"J Han","year":"2015","unstructured":"Han J, Byun MK, Lee J, et al. Longitudinal analysis of retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in ethambutol-induced optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2015;253(12):2293\u20139.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"2573_CR43","first-page":"1643","volume":"11","author":"D Teng","year":"2018","unstructured":"Teng D, Peng CX, Qian HY, et al. Structural impairment patterns in peripapillary retinal fiber layer and retinal ganglion cell layer in mitochondrial optic neuropathies. Int J Ophthalmol. 2018;11(10):1643\u20138.","journal-title":"Int J Ophthalmol"},{"issue":"3","key":"2573_CR44","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/WNO.0000000000000229","volume":"35","author":"LM Vieira","year":"2015","unstructured":"Vieira LM, Silva NF, Dias DSA, et al. Retinal ganglion cell layer analysis by optical coherence tomography in toxic and nutritional optic neuropathy. J Neuroophthalmol. 2015;35(3):242\u20135.","journal-title":"J Neuroophthalmol"},{"issue":"6","key":"2573_CR45","doi-asserted-by":"publisher","first-page":"414","DOI":"10.5414\/NPP27414","volume":"27","author":"R Pommer","year":"2008","unstructured":"Pommer R, Schoeler S, Mawrin C, Szibor R, Kirches E. The G11778A LHON mutation does not enhance ethambutol cytotoxicity in a cybrid model. Clin Neuropathol. 2008;27(6):414\u201323.","journal-title":"Clin Neuropathol"},{"issue":"5","key":"2573_CR46","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s004150050223","volume":"245","author":"MT Dotti","year":"1998","unstructured":"Dotti MT, Plewnia K, Cardaioli E, et al. A case of ethambutol-induced optic neuropathy harbouring the primary mitochondrial LHON mutation at nt 11778. J Neurol. 1998;245(5):302\u20133.","journal-title":"J Neurol"},{"issue":"8","key":"2573_CR47","first-page":"743","volume":"113","author":"X Feng","year":"2000","unstructured":"Feng X, Pu W, Gao D, Isashiki Y, Ohba N. Diagnostic potential of mitochondrial DNA assessment in patients with optic neuropathy. Chin Med J (Engl). 2000;113(8):743\u20136.","journal-title":"Chin Med J (Engl)"},{"key":"2573_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fnins.2019.00057","volume":"13","author":"R Nuzzi","year":"2019","unstructured":"Nuzzi R, Scalabrin S, Becco A, Panzica G. Sex hormones and optic nerve disorders: a review. Front Neurosci. 2019;13:57.","journal-title":"Front Neurosci"},{"issue":"3","key":"2573_CR49","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10571-020-00859-6","volume":"41","author":"JC Means","year":"2021","unstructured":"Means JC, Lopez AA, Koulen P. Estrogen protects optic nerve head astrocytes against oxidative stress by preventing caspase-3 activation, tau dephosphorylation at Ser(422) and the formation of tau protein aggregates. Cell Mol Neurobiol. 2021;41(3):449\u201358.","journal-title":"Cell Mol Neurobiol"},{"issue":"4","key":"2573_CR50","volume":"14","author":"D Rana","year":"2022","unstructured":"Rana D, Patel S, Roy T, Bailey JW. A case report: ethambutol causes a rare adverse effect of peripheral neuropathy. Cureus. 2022;14(4): e23782.","journal-title":"Cureus"},{"key":"2573_CR51","volume":"77","author":"S Shah","year":"2022","unstructured":"Shah S, Adhikari YR, Paudel S, et al. Optic neuropathy induced by ethambutol: a rare case from Nepal. Ann Med Surg (Lond). 2022;77: 103637.","journal-title":"Ann Med Surg (Lond)"},{"issue":"3","key":"2573_CR52","doi-asserted-by":"publisher","first-page":"288","DOI":"10.5507\/bp.2022.022","volume":"167","author":"M Kyncl","year":"2023","unstructured":"Kyncl M, Fus M, Lestak J. Ethambutol-induced optic neuropathy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2023;167(3):288\u201393.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"issue":"9","key":"2573_CR53","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.4103\/ijo.IJO_2996_21","volume":"70","author":"S Ambika","year":"2022","unstructured":"Ambika S, Lakshmi KP, Gopal M, Noronha OV. Visual outcomes of toxic optic neuropathy secondary to ethambutol: a retrospective observational study from India, an endemic country. Indian J Ophthalmol. 2022;70(9):3388\u201392.","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"2573_CR54","doi-asserted-by":"publisher","first-page":"343","DOI":"10.4103\/tjo.tjo_27_21","volume":"12","author":"YW Lin","year":"2022","unstructured":"Lin YW, Wang JK, Huang TL. Ethambutol optic neuropathy with correspondent chiasmitis manifestation in magnetic resonance imaging. Taiwan J Ophthalmol. 2022;12(3):343\u20136.","journal-title":"Taiwan J Ophthalmol"},{"issue":"3","key":"2573_CR55","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ijtb.2020.09.014","volume":"68","author":"VS Murumkar","year":"2021","unstructured":"Murumkar VS, Biswas S, Saini JS, Prabhuraj AR. Neuroimaging in ethambutol induced optic neuropathy: MRI in time can save the vision. Indian J Tuberc. 2021;68(3):408\u201311.","journal-title":"Indian J Tuberc"},{"key":"2573_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2025.03.002","author":"J Kim","year":"2025","unstructured":"Kim J, Ahn SJ. Ethambutol optic neuropathy surveillance: variations in real-world screening practices and associated factors in a nationwide cohort study. Clin Ther. 2025. https:\/\/doi.org\/10.1016\/j.clinthera.2025.03.002.","journal-title":"Clin Ther"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02573-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02573-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02573-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T09:03:52Z","timestamp":1745399032000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02573-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2573"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02573-9","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"23 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involving human participants was reviewed and approved by the Ethics Review Committee of Zhongshan Ophthalmic Center. Written informed consent to participate in the study was obtained from the participants'legal guardians or next of kin. Written informed consent was also obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"321"}}